MRC1 and cancer: In addition, SNAI2 levels were also found to be closely related to immune infiltrating cell expression, immune checkpoint gene expression, TMB, MSI, MMR gene, DNA methylation, etc. Our careful analysis of this study provided insights into the significant immunological advantages of SNAI2 as a pan-cancer prognostic and immunotherapy biomarker.